Locanabio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
Locanabio to report preclinical data from snRNA exon skipping program in DMD and Cas13d-mediated C9orf72 ALS program SAN DIEGO, May…
Pharmaceuticals, Biotechnology and Life Sciences
Locanabio to report preclinical data from snRNA exon skipping program in DMD and Cas13d-mediated C9orf72 ALS program SAN DIEGO, May…
CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) — Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of…
ROCKVILLE, Md., May 01, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company…
For the Year Ended December 31, 2022 as Compared to the Same Period of the Prior Year, AGRA’s Decrease in…
Joint Venture Logo Cortexa, a joint venture of PharmAla Biotech and Vitura Health, is the first company specifically formed to…
MALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a pharmaceutical…
LA JOLLA, Calif., April 30, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
FVC Change from Baseline over 24 Weeks: ITT Population | ITT Population- SoC Subgroup Figure 1. Change in FVC from…
Press release FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Eric Nys, general manager, [email protected] Dividend…
HAYWARD, Calif., April 28, 2023 (GLOBE NEWSWIRE) — Predicine, a global molecular insights company, announced today that it will present…